Delivery Order SPE2DB22D2005-SPE2DB24FJKY1
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,564,235,087 units of Ondansetron ODT 4 mg tablets. The $4,464.67 contract has an ultimate completion date of April 11, 2024 and does not utilize any set-aside designations. AmerisourceBergen Drug Corp is the prime contractor and serves as the primary supplier of pharmaceutical products and medical supplies to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of Ondansetron ODT 4 mg tablets. The order, valued at $3,672.70, has a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $18,770.38 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,563,604,432 units of ondansetron ODT 4 mg tablets. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of ondansetron ODT 4 mg tablets. The contract has a completion date of January 30, 2024 and a potential value of $5,983.56. Amerisourcebergen Drug Corp is the prime contractor and this delivery order is part of a larger indefinite delivery contract (IDC) with DLA valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Ondansetron ODT 4 mg tablets. The contract has a completion date of January 30, 2024 and a potential value of $6,528.94. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. This IDC...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for 4,563,943,300 Ondansetron ODT 4 mg tablets. The delivery order is valued at $2,256.20 and has a period of performance through March 13, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,528.76 contract is for the supply of 4,564,885,759 units of the pharmaceutical product Ondansetron ODT 4 mg tablets, with an ultimate completion date of June 13, 2024. Amerisourcebergen, a large pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,249,283 units of the pharmaceutical product Ondansetron ODT 4 mg Tablet 30s. The award, valued at $6,719.95, has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA valued up to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $5,014.40 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of ondansetron ODT 4 mg tablets. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Ondansetron ODT 4 mg tablets. The contract has a potential value of $1,721.02 and a completion date of February 13, 2024. Amerisourcebergen Drug Corp, a for-profit organization, provides pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense. This delivery order...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB24FJKY1Delivery Order
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $1,915.38 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,564,205 units of the pharmaceutical product Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This delivery order falls under the IDC and does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 4/8/24 |